Axcelis Technologies Inc
ACLS65.070USD
-3.840-5.57%
Close 06/13, 16:00（ET）Quotes delayed by 15 min
2.09BMarket Cap
10.40P/E TTM
More Details of Axcelis Technologies Inc Company
Axcelis Technologies, Inc. provides high-productivity solutions for the semiconductor industry. The Company is focused on developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the critical and enabling steps in the IC manufacturing process. Its ion implantation products include high current ion implant, high energy ion implant and medium current ion implant. The Company's Purion H, Purion Dragon, Purion H200, and GSD/E2 Ovation spot beam, high current systems cover all traditional high current requirements as well as those associated with emerging and future devices. Its Purion XE, EXE, and other Purion high energy systems combine its production-proven RF Linac high energy, spot beam technology with the Purion platform wafer handling system. Its medium current ion implant products include its Purion M Si and SiC medium current systems. It also offers its customers aftermarket service and support.
Company Info
Ticker SymbolACLS
Company nameAxcelis Technologies Inc
IPO dateJul 11, 2000
Founded at1995
CEODr. Russell J. Low, Ph.D.
Number of employees1524
Security typeOrdinary Share
Fiscal year-endJul 11
Address108 Cherry Hill Dr
CityBEVERLY
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code01915
Phone19782324001
Websitehttps://www.axcelis.com/
Ticker SymbolACLS
IPO dateJul 11, 2000
Founded at1995
Company Executives
Name
Name/Position
Position
Shareholding
Change
Dr. Russell J. Low, Ph.D.
Dr. Russell J. Low, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
97.27K
+139.40%
Mr. James Gordon Coogan
Mr. James Gordon Coogan
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
26.93K
+824.16%
Mr. Gerald M. Blumenstock
Mr. Gerald M. Blumenstock
Executive Vice President - Research, Development and Engineering
Executive Vice President - Research, Development and Engineering
14.08K
+561.61%
Ms. Jeanne Quirk, CPA
Ms. Jeanne Quirk, CPA
Independent Director
Independent Director
11.18K
+47.24%
Mr. Jorge Luis Titinger
Mr. Jorge Luis Titinger
Independent Chairman of the Board
Independent Chairman of the Board
9.48K
+60.87%
Mr. Gregory B. Graves
Mr. Gregory B. Graves
Director
Director
6.25K
+134.46%
Dr. Necip Sayiner, Ph.D.
Dr. Necip Sayiner, Ph.D.
Director
Director
6.25K
+134.46%
Mr. Thomas St. Dennis
Mr. Thomas St. Dennis
Independent Director
Independent Director
--
--
Ms. Eileen J. Evans
Ms. Eileen J. Evans
Executive Vice President, General Counsel
Executive Vice President, General Counsel
--
--
Mr. John T. Kurtzweil
Mr. John T. Kurtzweil
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Russell J. Low, Ph.D.
Dr. Russell J. Low, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
97.27K
+139.40%
Mr. James Gordon Coogan
Mr. James Gordon Coogan
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
26.93K
+824.16%
Mr. Gerald M. Blumenstock
Mr. Gerald M. Blumenstock
Executive Vice President - Research, Development and Engineering
Executive Vice President - Research, Development and Engineering
14.08K
+561.61%
Ms. Jeanne Quirk, CPA
Ms. Jeanne Quirk, CPA
Independent Director
Independent Director
11.18K
+47.24%
Mr. Jorge Luis Titinger
Mr. Jorge Luis Titinger
Independent Chairman of the Board
Independent Chairman of the Board
9.48K
+60.87%
Mr. Gregory B. Graves
Mr. Gregory B. Graves
Director
Director
6.25K
+134.46%
Revenue Breakdown
Currency: USDUpdated: Sun, Apr 6
Currency: USDUpdated: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Ion Implantation Systems Services And Royalties
1.00B
98.35%
Other Products Systems Services And Royalties
16.82M
1.65%
By RegionUSD
Name
Revenue
Proportion
United States
632.03M
62.09%
Asia Pacific
347.75M
34.16%
Europe
38.09M
3.74%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Ion Implantation Systems Services And Royalties
1.00B
98.35%
Other Products Systems Services And Royalties
16.82M
1.65%
Shareholding Stats
Updated: Fri, May 16
Updated: Fri, May 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
14.87%
The Vanguard Group, Inc.
13.80%
Reinhart Partners, LLC
4.49%
State Street Global Advisors (US)
3.88%
American Century Investment Management, Inc.
3.55%
Other
59.42%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
14.87%
The Vanguard Group, Inc.
13.80%
Reinhart Partners, LLC
4.49%
State Street Global Advisors (US)
3.88%
American Century Investment Management, Inc.
3.55%
Other
59.42%
Shareholder Types
Shareholders
Proportion
Investment Advisor
52.11%
Investment Advisor/Hedge Fund
36.13%
Research Firm
7.07%
Hedge Fund
4.46%
Pension Fund
2.10%
Sovereign Wealth Fund
1.65%
Individual Investor
1.61%
Bank and Trust
0.82%
Family Office
0.05%
Institutional Shareholding
Updated: Sat, Feb 22
Updated: Sat, Feb 22
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
924
32.61M
101.49%
-5.53M
2024Q4
929
32.57M
101.28%
-3.70M
2024Q3
903
31.79M
97.79%
-4.05M
2024Q2
902
32.20M
98.74%
-3.39M
2024Q1
879
31.53M
96.69%
-2.62M
2023Q4
836
30.44M
93.12%
-1.97M
2023Q3
786
30.88M
94.23%
-1.26M
2023Q2
736
30.61M
93.23%
-613.29K
2023Q1
671
30.11M
92.00%
-1.31M
2022Q4
621
30.49M
93.03%
-527.14K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
4.89M
15.2%
+76.30K
+1.58%
Dec 31, 2024
The Vanguard Group, Inc.
4.39M
13.64%
+106.20K
+2.48%
Dec 31, 2024
Reinhart Partners, LLC
1.04M
3.22%
+348.50K
+50.68%
Dec 31, 2024
State Street Global Advisors (US)
1.30M
4.04%
+67.91K
+5.51%
Dec 31, 2024
American Century Investment Management, Inc.
1.06M
3.29%
+290.68K
+37.78%
Dec 31, 2024
BNP Paribas Asset Management USA, Inc.
561.10K
1.74%
+82.17K
+17.16%
Dec 31, 2024
Geode Capital Management, L.L.C.
897.75K
2.79%
+23.23K
+2.66%
Dec 31, 2024
PRIMECAP Management Company
916.43K
2.85%
-58.01K
-5.95%
Dec 31, 2024
Boston Trust Walden Company
820.12K
2.55%
+313.69K
+61.94%
Dec 31, 2024
View more
Related ETFs
Updated: Fri, Jun 6
Updated: Fri, Jun 6
Name
Proportion
ProShares Nanotechnology ETF
4.08%
Janus Henderson Small Cap Growth Alpha ETF
1.61%
Invesco S&P SmallCap Information Technology ETF
1.27%
Acquirers Small and Micro Deep Value ETF
1.16%
Invesco S&P SmallCap 600 GARP ETF
1.12%
Optimize Strategy Index ETF
1.05%
SPDR FactSet Innovative Technology ETF
0.86%
First Trust Small Cap Value AlphaDEX Fund
0.63%
Invesco NASDAQ Future Gen 200 ETF
0.62%
Distillate Small/Mid Cash Flow ETF
0.61%
View more
ProShares Nanotechnology ETF
Proportion4.08%
Janus Henderson Small Cap Growth Alpha ETF
Proportion1.61%
Invesco S&P SmallCap Information Technology ETF
Proportion1.27%
Acquirers Small and Micro Deep Value ETF
Proportion1.16%
Invesco S&P SmallCap 600 GARP ETF
Proportion1.12%
Optimize Strategy Index ETF
Proportion1.05%
SPDR FactSet Innovative Technology ETF
Proportion0.86%
First Trust Small Cap Value AlphaDEX Fund
Proportion0.63%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.62%
Distillate Small/Mid Cash Flow ETF
Proportion0.61%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
